[SCHEDULE 13G/A Amendment No. 9 China Cord Blood Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 698659109 (CUSIP Number) September 29, 2015 (Date of Event Which Requires Filing of this Statement) ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) *The remainder of this cover page shall be filled out for a]
[Execution Version TERMINATION AGREEMENT THIS TERMINATION AGREEMENT Agreement BETWEEN: (1) BRILLIANT CHINA HEALTHCARE INVESTMENT LIMITED Seller (2) GOLDEN MEDITECH HOLDINGS LIMITED Purchaser Party Parties RECITALS: (A) Purchase Agreement The Parties entered into a purchase agreement, dated as of May 4, 2015 (the " (B) The Parties wish to terminate the Purchase Agreement upon the terms and subject to the conditions] [Execution Version TERMINATION DEED THIS TERMINATION DEED Deed AMONG: (1) Mr. KAM YUEN ( 甘源 ) , Mr. Kam (2) BIO GARDEN INC. Bio Garden") (3) BRILLIANT CHINA HEALTHCARE INVESTMENT LIMITED Seller Party Parties RECITALS: (A) Purchaser Purchase Agreement Transaction The Seller and Golden Meditech Holdings Limited (the " (B) Voting Deed Mr. Kam, Bio Garden and the Seller entered] [Execution Version SHARE PURCHASE AGREEMENT THIS SHARE PURCHASE AGREEMENT Agreement BETWEEN: (1) BRILLIANT CHINA HEALTHCARE INVESTMENT LIMITED Seller (2) MAGNUM OPUS 2 INTERNATIONAL HOLDINGS LIMITED Purchaser Party Parties RECITALS: (A) SPV Sale Shares Shares SPV The Seller owns all the issued and outstanding shares (the " (B) Notes CCBC (C) CCBC Shares NYSE The Notes are convertible into ordinary shares] [Dated this 26 August 2015 B Y : Magnum Opus 2 International Holdings Limited IN FAVOUR OF: BRILLIANT CHINA HEALTHCARE INVESTMENT LIMITED CHARGE OVER SHARES IN EXCELLENT CHINA HEALTHCARE INVESTMENT LIMITED Conyers Dill & Pearman Attorneys at Law Cayman Islands TABLE OF CONTENTS 1 INTERPRETATION 3 2 5 3 CHARGOR’S COVENANTS 6 4 SECURITY 7 5 DEALINGS WITH CHARGED PROPERTY] [Execution Version Letter of Undertaking to Seller PO Box 309, Ugland House, Grand Cayman KY1-1104 Cayman Islands Dear Sirs, Re: Purchase of SPV Sale Shares Background MO2 GM SPV Notes CCBC Excellent China Healthcare Investment Limited (' The Notes are convertible into the ordinary shares of CCBC of par value US$0.0001 per share. KKR SPV Share Agreement SPV Share Agreement] [Was h i n g t o n , D . C . 2 05 4 9 SCHEDULE 13D (Rule 13d-1 and Rule 13d-2) (Amendment No. 3) CHINA CORD BLOOD CORPORATION (Name of Issuer) Ordinary Shares, par value $0.0001 (Title of Class of Securities) G21107100 (CUSIP Number) David J. Sorkin, Esq. Kohlberg Kravis Roberts & Co. L.P. 9 West 57th]
[Execution Version TERMINATION AGREEMENT THIS TERMINATION AGREEMENT Agreement BETWEEN: (1) BRILLIANT CHINA HEALTHCARE INVESTMENT LIMITED Seller (2) GOLDEN MEDITECH HOLDINGS LIMITED Purchaser Party Parties RECITALS: (A) Purchase Agreement The Parties entered into a purchase agreement, dated as of May 4, 2015 (the " (B) The Parties wish to terminate the Purchase Agreement upon the terms and subject to the conditions] [Execution Version TERMINATION DEED THIS TERMINATION DEED Deed AMONG: (1) Mr. KAM YUEN ( 甘源 ) , Mr. Kam (2) BIO GARDEN INC. Bio Garden") (3) BRILLIANT CHINA HEALTHCARE INVESTMENT LIMITED Seller Party Parties RECITALS: (A) Purchaser Purchase Agreement Transaction The Seller and Golden Meditech Holdings Limited (the " (B) Voting Deed Mr. Kam, Bio Garden and the Seller entered] [Execution Version SHARE PURCHASE AGREEMENT THIS SHARE PURCHASE AGREEMENT Agreement BETWEEN: (1) BRILLIANT CHINA HEALTHCARE INVESTMENT LIMITED Seller (2) MAGNUM OPUS 2 INTERNATIONAL HOLDINGS LIMITED Purchaser Party Parties RECITALS: (A) SPV Sale Shares Shares SPV The Seller owns all the issued and outstanding shares (the " (B) Notes CCBC (C) CCBC Shares NYSE The Notes are convertible into ordinary shares] [Dated this 26 August 2015 B Y : Magnum Opus 2 International Holdings Limited IN FAVOUR OF: BRILLIANT CHINA HEALTHCARE INVESTMENT LIMITED CHARGE OVER SHARES IN EXCELLENT CHINA HEALTHCARE INVESTMENT LIMITED Conyers Dill & Pearman Attorneys at Law Cayman Islands TABLE OF CONTENTS 1 INTERPRETATION 3 2 5 3 CHARGOR’S COVENANTS 6 4 SECURITY 7 5 DEALINGS WITH CHARGED PROPERTY] [Execution Version Letter of Undertaking to Seller PO Box 309, Ugland House, Grand Cayman KY1-1104 Cayman Islands Dear Sirs, Re: Purchase of SPV Sale Shares Background MO2 GM SPV Notes CCBC Excellent China Healthcare Investment Limited (' The Notes are convertible into the ordinary shares of CCBC of par value US$0.0001 per share. KKR SPV Share Agreement SPV Share Agreement] [Was h i n g t o n , D . C . 2 05 4 9 SCHEDULE 13D (Rule 13d-1 and Rule 13d-2) (Amendment No. 3) CHINA CORD BLOOD CORPORATION (Name of Issuer) Ordinary Shares, par value $0.0001 (Title of Class of Securities) G21107100 (CUSIP Number) David J. Sorkin, Esq. Kohlberg Kravis Roberts & Co. L.P. 9 West 57th]
[Joint Filing Agreement [Remainder of Page Intentionally Left Blank] GOLDEN MEDITECH STEM CELLS (BVI) COMPANY LIMITED GOLDEN MEDITECH HOLDINGS LIMITED BIO GARDEN INC.] [Execution Version SHARE PURCHASE A THIS SHARE PURCHASE A Agreement BETWEEN : (1) BRILLIANT CHINA HEALTHCARE INVESTMENT LIMITED Seller (2) MAGNUM OPUS 2 INTERNATIONAL HOLDINGS LIMITED Purchaser Party Parties RECITALS: (A) SPV Sale Share s Share s SPV (B) Notes CCBC (C) CCBC Share s NYSE (D) (E) GM 1 AGREEMENT: SECTION 1 INTERPRETATION 1.1 Definitions A cquisition A] [Dated this 26 August 2015 B Y : Magnum Opus 2 International Holdings Limited IN FAVOUR OF: BRILLIANT CHINA HEALTHCARE INVESTMENT LIMITED CHARGE OVER SHARES IN EXCELLENT CHINA HEALTHCARE INVESTMENT LIMITED Conyers Dill & Pearman Attorneys at Law Cayman Islands TABLE OF CONTENTS 1 INTERPRETATION 3 2 5 3 CHARGORS COVENANTS 6 4 SECURITY] [Letter of Undertaking Golden Meditech Holdings Limited (GM) 48/F, Bank of China Tower 1 Garden Road Central Hong Kong Dear Sirs, Re: grant of option to acquire the Notes Background MO2 KKR SPV Notes CCBC Excellent China Healthcare Investment Limited ( Underlying CCBC Shares The Notes are convertible into the ordinary shares of CCBC of par value US$0.0001 per share] [Execution Version Letter of Undertaking to Seller BRILLIANT CHINA HEALTHCARE INVESTMENT LIMITED PO Box 309, Ugland House, Grand Cayman KY1-1104 Cayman Islands Dear Sirs, Re: Purchase of SPV Sale Shares Background MO2 GM Excellent China Healthcare Investment Limited SPV Notes CCBC The Notes are convertible into the ordinary shares of CCBC of par value US$0.0001 per share. KKR SPV Share] [Execution Version TERMINATION A THIS TERMINATION A Agreement BETWEEN : (1) BRILLIANT CHINA HEALTHCARE INVESTMENT LIMITED Seller (2) GOLDEN MEDITECH HOLDINGS LIMITED Purchaser Party Parties RECITALS: (A) Purchase Agreement ( AGREEMENT: 1. Termination of the Purchase Agreement 2. Governing Law and Dispute Resolution 3. Amendment 4. Counterparts [ ] 1 IN WITNESS WHEREOF this Agreement has been executed on the] [Execution Version TERMINATION DEED THIS TERMINATION DEED Deed AMONG : (1) Mr. KAM YUEN ( 甘源 ) Mr. Kam (2) BIO GARDEN INC. Bio Garden) (3) BRILLIANT CHINA HEALTHCARE INVESTMENT LIMITED Seller Party Parties RECITALS: (A) Purchaser Purchase Agreement Transaction (B) Voting Deed (B) (B) NOW THIS DEED WITNESSES 1. Termination of the Voting Deed 2. Governing Law and Dispute] []
[Joint Filing Agreement [Remainder of Page Intentionally Left Blank] GOLDEN MEDITECH STEM CELLS (BVI) COMPANY LIMITED GOLDEN MEDITECH HOLDINGS LIMITED BIO GARDEN INC.] [Execution Version SHARE PURCHASE A THIS SHARE PURCHASE A Agreement BETWEEN : (1) BRILLIANT CHINA HEALTHCARE INVESTMENT LIMITED Seller (2) MAGNUM OPUS 2 INTERNATIONAL HOLDINGS LIMITED Purchaser Party Parties RECITALS: (A) SPV Sale Share s Share s SPV (B) Notes CCBC (C) CCBC Share s NYSE (D) (E) GM 1 AGREEMENT: SECTION 1 INTERPRETATION 1.1 Definitions A cquisition A] [Dated this 26 August 2015 B Y : Magnum Opus 2 International Holdings Limited IN FAVOUR OF: BRILLIANT CHINA HEALTHCARE INVESTMENT LIMITED CHARGE OVER SHARES IN EXCELLENT CHINA HEALTHCARE INVESTMENT LIMITED Conyers Dill & Pearman Attorneys at Law Cayman Islands TABLE OF CONTENTS 1 INTERPRETATION 3 2 5 3 CHARGORS COVENANTS 6 4 SECURITY] [Letter of Undertaking Golden Meditech Holdings Limited (GM) 48/F, Bank of China Tower 1 Garden Road Central Hong Kong Dear Sirs, Re: grant of option to acquire the Notes Background MO2 KKR SPV Notes CCBC Excellent China Healthcare Investment Limited ( Underlying CCBC Shares The Notes are convertible into the ordinary shares of CCBC of par value US$0.0001 per share] [Execution Version Letter of Undertaking to Seller BRILLIANT CHINA HEALTHCARE INVESTMENT LIMITED PO Box 309, Ugland House, Grand Cayman KY1-1104 Cayman Islands Dear Sirs, Re: Purchase of SPV Sale Shares Background MO2 GM Excellent China Healthcare Investment Limited SPV Notes CCBC The Notes are convertible into the ordinary shares of CCBC of par value US$0.0001 per share. KKR SPV Share] [Execution Version TERMINATION A THIS TERMINATION A Agreement BETWEEN : (1) BRILLIANT CHINA HEALTHCARE INVESTMENT LIMITED Seller (2) GOLDEN MEDITECH HOLDINGS LIMITED Purchaser Party Parties RECITALS: (A) Purchase Agreement ( AGREEMENT: 1. Termination of the Purchase Agreement 2. Governing Law and Dispute Resolution 3. Amendment 4. Counterparts [ ] 1 IN WITNESS WHEREOF this Agreement has been executed on the] [Execution Version TERMINATION DEED THIS TERMINATION DEED Deed AMONG : (1) Mr. KAM YUEN ( 甘源 ) Mr. Kam (2) BIO GARDEN INC. Bio Garden) (3) BRILLIANT CHINA HEALTHCARE INVESTMENT LIMITED Seller Party Parties RECITALS: (A) Purchaser Purchase Agreement Transaction (B) Voting Deed (B) (B) NOW THIS DEED WITNESSES 1. Termination of the Voting Deed 2. Governing Law and Dispute] []
[China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2016 1Q16 Added 16,090 New Subscribers 1Q16 Revenue Up 7.8% YOY to RMB165.4 Million ($26.7 Million) 1Q16 Operating Income Amounted to RMB48.4 Million ($7.8 Million) Conference Call to be Held on August 20, 2015 at 8:00 a.m. ET HONG KONG, China, August 19, 2015 China Cord] [FORM 6-K For the month of August 2015 CHINA CORD BLOOD CORPORATION 48 th Floor, Bank of China Tower Form 20-F x Form 40-F o ¨ ¨ Yes o No x EXPLANATORY NOTE 2 Results of Operations and Financial Condition Following this cover page are the preliminary unaudited condensed consolidated financial results for the three months ended June 30, 2015]
[China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2016 1Q16 Added 16,090 New Subscribers 1Q16 Revenue Up 7.8% YOY to RMB165.4 Million ($26.7 Million) 1Q16 Operating Income Amounted to RMB48.4 Million ($7.8 Million) Conference Call to be Held on August 20, 2015 at 8:00 a.m. ET HONG KONG, China, August 19, 2015 China Cord] [FORM 6-K For the month of August 2015 CHINA CORD BLOOD CORPORATION 48 th Floor, Bank of China Tower Form 20-F x Form 40-F o ¨ ¨ Yes o No x EXPLANATORY NOTE 2 Results of Operations and Financial Condition Following this cover page are the preliminary unaudited condensed consolidated financial results for the three months ended June 30, 2015]
[FORM 20-F o OR x OR o For the transition period from to OR o Date of event requiring this shell company report: China Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48 th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albert Chen +852 3605 8180 albert.chen@chinacordbloodcorp.com 48 th Floor, Bank of China] [List of Subsidiaries Name Jurisdiction China Cord Blood Services Corporation Cayman Islands China Stem Cells Holdings Limited Cayman Islands Beijing Jiachenhong Biological Technologies Co., Ltd. Peoples Republic of China Guangzhou Municipality Tianhe Nuoya Bio-engineering Co., Ltd. Peoples Republic of China Zhejiang Lukou Biotechnology Co., Ltd. Peoples Republic of China China Stem Cells (East) Company Limited British Virgin Islands China Stem] [Certification I, Ting Zheng, certify that: 1. I have reviewed this annual report on Form 20-F of China Cord Blood Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification I, Albert Chen, certify that: 1. I have reviewed this annual report on Form 20-F of China Cord Blood Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification CHINA CORD BLOOD CORPORATION July 31, 2015 Ting Zheng Chief Executive Officer July 31, 2015 Albert Chen Chief Financial Officer (Principal Financial Officer) EX-13.1 5 a15-6996_1ex13d1.htm EX-13.1] [Consent of Independent Registered Public Accounting Firm The Board of Directors China Cord Blood Corporation: Hong Kong, China July 31, 2015 EX-15.1 6 a15-6996_1ex15d1.htm EX-15.1]
